Calcium channel blocker toxicity: Difference between revisions
From WikiMD's Wellness Encyclopedia
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
{{SI}} | |||
{{Infobox medical condition | |||
| name = Calcium channel blocker toxicity | |||
| image = [[File:LipidEmulsion.JPG|left|thumb|Lipid emulsion therapy]] | |||
| caption = Lipid emulsion therapy, a treatment for severe cases | |||
| field = [[Toxicology]] | |||
| symptoms = [[Hypotension]], [[bradycardia]], [[dizziness]], [[nausea]], [[vomiting]], [[confusion]], [[hyperglycemia]] | |||
| complications = [[Cardiac arrest]], [[shock]], [[metabolic acidosis]] | |||
| onset = Within hours of overdose | |||
| duration = Variable, depending on severity and treatment | |||
| causes = Overdose of [[calcium channel blockers]] | |||
| risks = [[Polypharmacy]], [[renal impairment]], [[liver impairment]] | |||
| diagnosis = Clinical evaluation, [[blood tests]], [[electrocardiogram]] | |||
| differential = [[Beta blocker toxicity]], [[digoxin toxicity]], [[myocardial infarction]] | |||
| prevention = Careful dosing, monitoring in high-risk patients | |||
| treatment = [[Activated charcoal]], [[intravenous fluids]], [[calcium]], [[vasopressors]], [[insulin therapy]], [[lipid emulsion therapy]] | |||
| prognosis = Variable, depends on dose and timeliness of treatment | |||
| frequency = Rare | |||
}} | |||
== Calcium Channel Blocker Toxicity == | == Calcium Channel Blocker Toxicity == | ||
[[File:LipidEmulsion.JPG|left|thumb|Lipid emulsion therapy is used in the treatment of calcium channel blocker toxicity.]] | |||
[[File:LipidEmulsion.JPG|thumb | |||
'''Calcium channel blocker toxicity''' is a potentially life-threatening condition resulting from an overdose of [[calcium channel blockers]] (CCBs), a class of medications commonly used to treat [[hypertension]], [[angina]], and certain [[cardiac arrhythmias]]. | '''Calcium channel blocker toxicity''' is a potentially life-threatening condition resulting from an overdose of [[calcium channel blockers]] (CCBs), a class of medications commonly used to treat [[hypertension]], [[angina]], and certain [[cardiac arrhythmias]]. | ||
== Pathophysiology == | == Pathophysiology == | ||
Calcium channel blockers work by inhibiting the influx of calcium ions through [[voltage-gated calcium channels]] in the [[heart]] and [[vascular smooth muscle]]. This action leads to decreased myocardial contractility, reduced heart rate, and vasodilation. In the case of an overdose, these effects are exaggerated, leading to severe [[hypotension]], [[bradycardia]], and potentially [[cardiogenic shock]]. | Calcium channel blockers work by inhibiting the influx of calcium ions through [[voltage-gated calcium channels]] in the [[heart]] and [[vascular smooth muscle]]. This action leads to decreased myocardial contractility, reduced heart rate, and vasodilation. In the case of an overdose, these effects are exaggerated, leading to severe [[hypotension]], [[bradycardia]], and potentially [[cardiogenic shock]]. | ||
== Clinical Presentation == | == Clinical Presentation == | ||
Patients with calcium channel blocker toxicity may present with a variety of symptoms, including: | Patients with calcium channel blocker toxicity may present with a variety of symptoms, including: | ||
* Severe [[hypotension]] | * Severe [[hypotension]] | ||
* [[Bradycardia]] | * [[Bradycardia]] | ||
| Line 19: | Line 31: | ||
* [[Confusion]] | * [[Confusion]] | ||
* [[Hyperglycemia]] | * [[Hyperglycemia]] | ||
In severe cases, patients may develop [[cardiac arrest]] or [[multi-organ failure]]. | In severe cases, patients may develop [[cardiac arrest]] or [[multi-organ failure]]. | ||
== Diagnosis == | == Diagnosis == | ||
Diagnosis of calcium channel blocker toxicity is primarily clinical, based on the history of ingestion and presenting symptoms. Laboratory tests may show elevated blood glucose levels and metabolic acidosis. [[Electrocardiogram|ECG]] findings may include bradycardia and conduction delays. | Diagnosis of calcium channel blocker toxicity is primarily clinical, based on the history of ingestion and presenting symptoms. Laboratory tests may show elevated blood glucose levels and metabolic acidosis. [[Electrocardiogram|ECG]] findings may include bradycardia and conduction delays. | ||
== Treatment == | == Treatment == | ||
The management of calcium channel blocker toxicity involves several steps: | The management of calcium channel blocker toxicity involves several steps: | ||
=== Initial Stabilization === | === Initial Stabilization === | ||
* Ensure adequate [[airway]], [[breathing]], and [[circulation]]. | * Ensure adequate [[airway]], [[breathing]], and [[circulation]]. | ||
* Administer [[intravenous fluids]] to support blood pressure. | * Administer [[intravenous fluids]] to support blood pressure. | ||
=== Specific Therapies === | === Specific Therapies === | ||
* '''Calcium:''' Administer intravenous calcium (calcium chloride or calcium gluconate) to counteract the effects of calcium channel blockade. | * '''Calcium:''' Administer intravenous calcium (calcium chloride or calcium gluconate) to counteract the effects of calcium channel blockade. | ||
* '''Vasopressors:''' Use [[vasopressors]] such as [[norepinephrine]] to maintain blood pressure. | * '''Vasopressors:''' Use [[vasopressors]] such as [[norepinephrine]] to maintain blood pressure. | ||
* '''High-dose insulin therapy:''' Administer high-dose insulin and glucose to improve cardiac contractility and peripheral perfusion. | * '''High-dose insulin therapy:''' Administer high-dose insulin and glucose to improve cardiac contractility and peripheral perfusion. | ||
* '''Lipid emulsion therapy:''' Intravenous lipid emulsion can be used as a "lipid sink" to sequester lipophilic drugs, as shown in the image. | * '''Lipid emulsion therapy:''' Intravenous lipid emulsion can be used as a "lipid sink" to sequester lipophilic drugs, as shown in the image. | ||
== Prognosis == | == Prognosis == | ||
The prognosis of calcium channel blocker toxicity depends on the amount ingested, the time to treatment, and the specific agent involved. Early recognition and aggressive treatment improve outcomes. | The prognosis of calcium channel blocker toxicity depends on the amount ingested, the time to treatment, and the specific agent involved. Early recognition and aggressive treatment improve outcomes. | ||
== See also == | |||
== | |||
* [[Calcium channel blocker]] | * [[Calcium channel blocker]] | ||
* [[Cardiac arrhythmia]] | * [[Cardiac arrhythmia]] | ||
* [[Hypertension]] | * [[Hypertension]] | ||
* [[Lipid emulsion therapy]] | * [[Lipid emulsion therapy]] | ||
{{Toxicology}} | {{Toxicology}} | ||
{{Cardiology}} | {{Cardiology}} | ||
[[Category:Toxicology]] | [[Category:Toxicology]] | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
Latest revision as of 20:56, 4 April 2025
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics
| Calcium channel blocker toxicity | |
|---|---|
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Hypotension, bradycardia, dizziness, nausea, vomiting, confusion, hyperglycemia |
| Complications | Cardiac arrest, shock, metabolic acidosis |
| Onset | Within hours of overdose |
| Duration | Variable, depending on severity and treatment |
| Types | N/A |
| Causes | Overdose of calcium channel blockers |
| Risks | Polypharmacy, renal impairment, liver impairment |
| Diagnosis | Clinical evaluation, blood tests, electrocardiogram |
| Differential diagnosis | Beta blocker toxicity, digoxin toxicity, myocardial infarction |
| Prevention | Careful dosing, monitoring in high-risk patients |
| Treatment | Activated charcoal, intravenous fluids, calcium, vasopressors, insulin therapy, lipid emulsion therapy |
| Medication | N/A |
| Prognosis | Variable, depends on dose and timeliness of treatment |
| Frequency | Rare |
| Deaths | N/A |
Calcium Channel Blocker Toxicity[edit]
Calcium channel blocker toxicity is a potentially life-threatening condition resulting from an overdose of calcium channel blockers (CCBs), a class of medications commonly used to treat hypertension, angina, and certain cardiac arrhythmias.
Pathophysiology[edit]
Calcium channel blockers work by inhibiting the influx of calcium ions through voltage-gated calcium channels in the heart and vascular smooth muscle. This action leads to decreased myocardial contractility, reduced heart rate, and vasodilation. In the case of an overdose, these effects are exaggerated, leading to severe hypotension, bradycardia, and potentially cardiogenic shock.
Clinical Presentation[edit]
Patients with calcium channel blocker toxicity may present with a variety of symptoms, including:
In severe cases, patients may develop cardiac arrest or multi-organ failure.
Diagnosis[edit]
Diagnosis of calcium channel blocker toxicity is primarily clinical, based on the history of ingestion and presenting symptoms. Laboratory tests may show elevated blood glucose levels and metabolic acidosis. ECG findings may include bradycardia and conduction delays.
Treatment[edit]
The management of calcium channel blocker toxicity involves several steps:
Initial Stabilization[edit]
- Ensure adequate airway, breathing, and circulation.
- Administer intravenous fluids to support blood pressure.
Specific Therapies[edit]
- Calcium: Administer intravenous calcium (calcium chloride or calcium gluconate) to counteract the effects of calcium channel blockade.
- Vasopressors: Use vasopressors such as norepinephrine to maintain blood pressure.
- High-dose insulin therapy: Administer high-dose insulin and glucose to improve cardiac contractility and peripheral perfusion.
- Lipid emulsion therapy: Intravenous lipid emulsion can be used as a "lipid sink" to sequester lipophilic drugs, as shown in the image.
Prognosis[edit]
The prognosis of calcium channel blocker toxicity depends on the amount ingested, the time to treatment, and the specific agent involved. Early recognition and aggressive treatment improve outcomes.
See also[edit]
| Toxicology | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Cardiovascular disease A-Z
Most common cardiac diseases
- Cardiac arrhythmia
- Cardiogenetic disorders
- Cardiomegaly
- Cardiomyopathy
- Cardiopulmonary resuscitation
- Chronic rheumatic heart diseases
- Congenital heart defects
- Heart neoplasia
- Ischemic heart diseases
- Pericardial disorders
- Syndromes affecting the heart
- Valvular heart disease
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
A[edit]
- Accelerated idioventricular rhythm
- Acute decompensated heart failure
- Arteriosclerotic heart disease
- Athletic heart syndrome
- Atrial flutter
- Atrioventricular fistula
- Cardiovascular disease in Australia
- Autoimmune heart disease
B[edit]
C[edit]
- Ebb Cade
- Cardiac allograft vasculopathy
- Cardiac amyloidosis
- Cardiac asthma
- Cardiac tamponade
- Cardiogenic shock
- Cardiogeriatrics
- Cardiorenal syndrome
- Cardiotoxicity
- Carditis
- Coronary artery aneurysm
- Coronary artery anomaly
- Coronary artery disease
- Spontaneous coronary artery dissection
- Coronary artery ectasia
- Coronary occlusion
- Coronary steal
- Coronary thrombosis
- Coronary vasospasm
- Cœur en sabot
- Coxsackievirus-induced cardiomyopathy
D[edit]
E[edit]
H[edit]
- Heart attack
- Heart failure
- Heart failure with preserved ejection fraction
- Heart to Heart (1949 film)
- High-output heart failure
- Hyperdynamic precordium
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
I[edit]
- Idiopathic giant-cell myocarditis
- Interventricular dyssynchrony
- Intraventricular dyssynchrony
- Isolated atrial amyloidosis
K[edit]
L[edit]
M[edit]
- Mydicar
- Myocardial bridge
- Myocardial disarray
- Myocardial rupture
- Myocardial scarring
- Myocardial stunning
- Myocarditis
N[edit]
O[edit]
P[edit]
- Papillary fibroelastoma
- Pathophysiology of heart failure
- Postpericardiotomy syndrome
- Pulmonary vein stenosis
R[edit]
S[edit]
- Saturated fat and cardiovascular disease
- SCAR-Fc
- Shone's syndrome
- Strain pattern
- Subacute bacterial endocarditis
- Sudden cardiac death of athletes
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
